Back
Intra-Cellular Therapies Stock Predictions
Sponsored
ITCI
Sponsored
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
26
ITCI
Intra-Cellular Therapies
Last Price:
77.64
Seasonality Move:
-4.41%
7 Day Trial
ALL ACCESS PASS
$
7
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.Intra-Cellular Therapies Stock Forecast
- Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 52.2% based on the past 10 years of stock performance.
- Intra-Cellular Therapies has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
-
Is Intra-Cellular Therapies Stock Undervalued?
The current Intra-Cellular Therapies [ITCI] share price is $76.97. The Score for ITCI is 26, which is 48% below its historic median score of 50, and infers higher risk than normal. - ITCI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Intra-Cellular Therapies Stock Go Up Next Year?
- Over the next 52 weeks, Intra-Cellular Therapies has on average historically risen by 52.2% based on the past 10 years of stock performance.
Intra-Cellular Therapies Stock Rating
Sell
26
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies overpriced?
- Intra-Cellular Therapies has risen higher in 7 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 70%
Intra-Cellular Therapies Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
intracellulartherapies.com
52-Week Data
52-Week High:
84.89
52-Week Low:
45.50
Prediction Charts
Market Cap:
8.13B
Price in USD:
76.97
Volume:
544.3K
Beta:
1.07
Technical Analysis
SMA50:
75.78
SMA100:
72.48
SMA200:
70.50
52-Wk Change:
41.59%
Stock Predictions
-
Is Intra-Cellular Therapies stock public?
Yes, Intra-Cellular Therapies is a publicly traded company. -
What is the Intra-Cellular Therapies stock quote today?
The Intra-Cellular Therapies stock price is 76.97 USD today. -
How to buy Intra-Cellular Therapies stock online?
You can buy Intra-Cellular Therapies shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Aug-30 | 72.27 | 73.28 | 73.48 | 72.21 |
Sep-3 | 73.30 | 73.01 | 74.73 | 72.61 |
Sep-4 | 72.61 | 72.66 | 73.09 | 71.75 |
Sep-5 | 73.13 | 72.46 | 73.13 | 71.80 |
Sep-6 | 74.89 | 73.52 | 76.12 | 73.02 |
Sep-9 | 73.86 | 74.41 | 76.34 | 73.71 |
Sep-10 | 74.80 | 73.56 | 75.16 | 73.22 |
Sep-11 | 73.62 | 74.71 | 74.92 | 73.05 |
Sep-12 | 74.55 | 75.24 | 75.85 | 74.10 |
Sep-13 | 75.55 | 75.38 | 76.98 | 74.95 |
Sep-16 | 75.75 | 75.26 | 76.60 | 75.21 |
Sep-17 | 75.27 | 75.11 | 76.56 | 74.67 |
Sep-18 | 74.95 | 74.68 | 75.72 | 74.46 |
Sep-19 | 75.12 | 76.97 | 77.18 | 74.62 |
Intra-Cellular Therapies Earnings
Intra-Cellular Therapies Earnings Report: Per Share Intra-Cellular Therapies Earnings Q1 Q2 Q3 and Q4 last year and next year.
Intra-Cellular Therapies Forecast Revenue Growth
Intra-Cellular Therapies Stock Analysis: Historical quarterly revenues per share for Intra-Cellular Therapies and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.23 per share, an increase this year of $0.97 per share, and an increase next year of $1.07 per share.
* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.